Itraconazole and antiretroviral therapy: strategies for empirical dosing.
Publication
, Journal Article
Schwartz, IS; Wasserman, S
Published in: Lancet Infect Dis
November 2017
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Lancet Infect Dis
DOI
EISSN
1474-4457
Publication Date
November 2017
Volume
17
Issue
11
Start / End Page
1122 / 1123
Location
United States
Related Subject Headings
- Microbiology
- Itraconazole
- Humans
- Hematologic Neoplasms
- HIV Infections
- Antifungal Agents
- 4202 Epidemiology
- 3207 Medical microbiology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
Citation
APA
Chicago
ICMJE
MLA
NLM
Schwartz, I. S., & Wasserman, S. (2017). Itraconazole and antiretroviral therapy: strategies for empirical dosing. Lancet Infect Dis, 17(11), 1122–1123. https://doi.org/10.1016/S1473-3099(17)30568-6
Schwartz, Ilan S., and Sean Wasserman. “Itraconazole and antiretroviral therapy: strategies for empirical dosing.” Lancet Infect Dis 17, no. 11 (November 2017): 1122–23. https://doi.org/10.1016/S1473-3099(17)30568-6.
Schwartz IS, Wasserman S. Itraconazole and antiretroviral therapy: strategies for empirical dosing. Lancet Infect Dis. 2017 Nov;17(11):1122–3.
Schwartz, Ilan S., and Sean Wasserman. “Itraconazole and antiretroviral therapy: strategies for empirical dosing.” Lancet Infect Dis, vol. 17, no. 11, Nov. 2017, pp. 1122–23. Pubmed, doi:10.1016/S1473-3099(17)30568-6.
Schwartz IS, Wasserman S. Itraconazole and antiretroviral therapy: strategies for empirical dosing. Lancet Infect Dis. 2017 Nov;17(11):1122–1123.
Published In
Lancet Infect Dis
DOI
EISSN
1474-4457
Publication Date
November 2017
Volume
17
Issue
11
Start / End Page
1122 / 1123
Location
United States
Related Subject Headings
- Microbiology
- Itraconazole
- Humans
- Hematologic Neoplasms
- HIV Infections
- Antifungal Agents
- 4202 Epidemiology
- 3207 Medical microbiology
- 3202 Clinical sciences
- 1117 Public Health and Health Services